Back
HFA Premium Access

Prognosis changes in patients with transthyretin cardiac amyloidosis after attr-act study.

Session: ePosters in chronic heart failure - epidemiology, prognosis, outcome 2
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor M. Galvan Ruiz (Las Palmas de Gran Canaria, ES)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Mario Galvan Ruiz

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)
0 follower

6 more presentations in this session

Prognostic impact of hyperuricemia in chronic heart failure with reduced ejection fraction

Speaker: Doctor C. Carvalho (Vila Real, PT)

Access
Abstract
Slides
Like
Thumbnail

Cystatin C is better than creatine for prognostic evaluation in heart failure patients

Speaker: Doctor F. Gerardo (Amadora, PT)

Access
Abstract
Slides
Like
Thumbnail

Comparison of the prognostic value of the 6-minute walk distance of patients with heart failure with and without sarcopenia

Speaker: Ms A. Kashima (Sagamihara, JP)

Access
Abstract
Slides
Like
Thumbnail

Remote heart failure symptom assessment after myocardial infarction identifies patients at risk of death

Speaker: Doctor D. Jenca (Prague, CZ)

Access
Abstract
Slides
Like
Thumbnail

Impact of genetic specialty referrals among patients with nonischemic cardiomyopathy and advanced heart failure

Speaker: Doctor R. Castro (New York, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

ePosters in chronic heart failure - epidemiology, prognosis, outcome 2

Speakers: Doctor M. Galvan Ruiz, Doctor C. Carvalho, Doctor F. Gerardo, Ms A. Kashima, Doctor D. Jenca...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources